A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1992
11/16/1992	WO1992020808A1 Genomic modifications with homologous dna targeting
11/16/1992	CA2092695A1 Genomic modifications with homologous dna targeting
11/15/1992	WO1992020708A1 Peptide inhibitors of inflammation
11/15/1992	WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection
11/15/1992	WO1992020325A1 Engineering the local inflammatory response as a means of controlled release drug delivery
11/15/1992	CA2103139A1 Peptide inhibitors of inflammation
11/15/1992	CA2103045A1 Engineering the local inflammatory response as a means of controlled release drug delivery
11/15/1992	CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection
11/14/1992	WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
11/14/1992	CA2068478A1 Peptide compound and a process for the preparation thereof
11/14/1992	CA2068389A1 Method for inhibiting bone resorption
11/12/1992	WO1992020060A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	WO1992019767A1 Methods to profile and treat abnormal cells
11/12/1992	WO1992019765A1 Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
11/12/1992	WO1992019760A1 In vitro methods for determining in vivo thrombotic events
11/12/1992	WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor
11/12/1992	WO1992019758A1 Transmission-blocking vaccine against malaria
11/12/1992	WO1992019757A1 Recombinant b oligomer of pertussis toxin
11/12/1992	WO1992019756A1 Monoclonal antibody specific for cathepsin l, hybridoma which produces the same, and method for using the same
11/12/1992	WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/12/1992	WO1992019749A1 Targeted delivery of genes encoding cell surface receptors
11/12/1992	WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics
11/12/1992	WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019734A1 Binding domains in notch and delta proteins
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019645A1 A novel polypeptide with affinity to lipopolysaccharides and their uses
11/12/1992	WO1992019644A1 Vasorelaxant peptide
11/12/1992	WO1992019639A1 Glycosylated prodrugs, method of preparation and use
11/12/1992	WO1992019635A1 Antigen recognized by antibodies associated with paraneoplastic opsoclonus and methods of use thereof
11/12/1992	WO1992019634A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens
11/12/1992	WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
11/12/1992	WO1992019280A1 Antivenom immunesera
11/12/1992	WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
11/12/1992	WO1992019263A1 Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
11/12/1992	WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/12/1992	WO1992019261A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract
11/12/1992	WO1992019260A1 Peptide hormone solution
11/12/1992	WO1992019258A1 Monospecific antibodies and antisera to the regulatory subunit of proline-directed protein kinase
11/12/1992	WO1992019257A1 Compositons for the treatment of chronic fatigue syndrome
11/12/1992	WO1992019256A1 New medicinal use
11/12/1992	WO1992019253A1 CCK ANALOGS CONTAINING α-SUBSTITUTED AMINO ACIDS
11/12/1992	WO1992019252A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	WO1992019248A1 High affinity mannose receptor ligands
11/12/1992	WO1992019244A2 A method for treating infectious respiratory diseases
11/12/1992	WO1992019236A1 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymaticglycosylation of proteins
11/12/1992	WO1992019224A2 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative
11/12/1992	WO1992019195A1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/12/1992	WO1992017151A3 Method of administering drugs through modification of epithelial tight junctions by tumor necrosis factor
11/12/1992	WO1992016181A3 Composition for promoting tissue repair and regeneration
11/12/1992	DE4115453A1 Neue wirkstoffkombination New drug combination
11/12/1992	CA2109528A1 A method for treating infectious respiratory diseases
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/12/1992	CA2107915A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof
11/12/1992	CA2106765A1 Cck analogs containing ó-substituted amino acids
11/12/1992	CA2102508A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	CA2068263A1 Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
11/11/1992	WO1992021031A1 PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS
11/11/1992	WO1992020714A1 Control of milk secretion
11/11/1992	WO1992020358A1 Novel biologically active peptide compositions and uses therefor
11/11/1992	EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them
11/11/1992	EP0512883A1 Concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use and its process of preparation
11/11/1992	EP0512844A1 Targeted delivery of bone growth factors
11/11/1992	EP0512750A1 Yeast derived mitogen
11/11/1992	EP0512733A2 Modified complement system regulator
11/11/1992	EP0512528A2 Pharmaceutical compositions comprising an anticytokine
11/11/1992	EP0512102A1 Proteins purified from mammalian gestational tissue which control cell proliferation
11/11/1992	EP0512076A1 Method of treating cancer using structured lipids
11/11/1992	EP0512042A1 Glp-1 analogs useful for diabetes treatment
11/11/1992	EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
11/11/1992	EP0511970A1 Method for preparing an enzymatic hydrolyzate.
11/11/1992	EP0303687B1 Compositions for enhancing adcc therapy
11/11/1992	EP0202300B1 Cdna clones coding for polypeptides exhibiting human granulocyte macrophage and eosinophil cellular growth factor activity
11/11/1992	CN1066070A Benzo-fused lactams that promote release of growth hormone
11/11/1992	CA2102808A1 Targeted delivery of bone growth factors
11/11/1992	CA2102800A1 Control of milk secretion
11/11/1992	CA2086605A1 Procedure for detecting and preparing anti-ige autoantibodies and use of these antibodies as active agents in diagnostic and therapeutic compositions
11/11/1992	CA2086111A1 Biologically active peptide compositions and uses therefor
11/10/1992	WO1992019648A1 Wf11243 substance
11/10/1992	WO1992019279A1 Phospholipid-targeted thrombolytic agents
11/10/1992	US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
11/10/1992	US5162504 Wich does not bind to non-prostatic antigens present in other tissues
11/10/1992	US5162502 Modified trichokirin and their preparation for use in conjugates as inhibitors of protein synthesis
11/10/1992	US5162500 Poststatin and related compounds or salts thereof
11/10/1992	US5162499 Synthetic peptides for the treatment of AIDS
11/10/1992	US5162497 Bradykinin analogs with non-peptide bond
11/10/1992	US5162430 To a synthetic hydrophilic polymer, polyoxyethylene glycol; wound healing, slow release drug delivery
11/10/1992	US5162374 Method for reversibly arresting muscle activity
11/10/1992	US5162373 Gut Atrophy Prevention, Ornithine, Methionine
11/10/1992	US5162366 Antioxidant composition in vivo comprising enol form δ-lactone of diketogulonic acid
11/10/1992	US5162362 Octahydroindole-2-carboxylic acids
11/10/1992	US5162348 Treatment of cystic fibrosis
11/10/1992	US5162306 Follicle Stimulating Hormone, Luteinizing Hormone
11/10/1992	US5162305 Polypeptide derivatives

1 ... 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 ... 3163